Antonio Eduardo Arce • H.C. Wainwright & Co.

Antonio Eduardo Arce is a Managing Director and Senior Equity Analyst at H.C. Wainwright & Co., specializing in healthcare sector research with a focus on biotechnology and pharmaceutical companies. He covers firms including Travere Therapeutics, Akero Therapeutics, Inventiva, and Sagimet Biosciences, with an average analyst return of 13.8% and a 45.4% success rate, according to TipRanks, and has documented over 998 price targets and ratings across 44 stocks. Arce has established a robust track record in stock recommendations, notably achieving a 108.25% return on Akero Therapeutics and consistently outperforming sector norms. He began his analyst career prior to joining H.C. Wainwright and maintains active FINRA registrations with securities licenses to support his professional credentials.